معرفی
Dipak Kotecha is a Professor of Cardiology and Cardiac Imaging at the University of Oxford (since 2019), University Medical Center Utrecht (since 2018), and Monash University (since 2008). His research focuses on
- Atrial fibrillation
- Heart failure
- Big data applications in cardiology
- Artificial intelligence-enhanced clinical approaches
His work integrates robust statistical evaluation and novel technologies like wearable devices, with a focus on trial methodology and patient involvement. Recent projects include the RATE-AF and STEEER-AF trials, exploring pharmacological optimization and guideline adherence in atrial fibrillation management.
Dr. Kotecha has received prestigious accolades, including the British Cardiovascular Society Michael Davies Award (2018) and the National Clinical Impact Award (2023). His leadership in clinical consensus statements and cluster-randomized trials underscores his influence in shaping cardiovascular care standards.
Key research trends from his recent publications (2025) include:
- Development of clinical consensus on atrial failure
- Cost-effectiveness analyses in atrial fibrillation therapy
- Education programs for guideline adherence in healthcare
- AI-driven pharmacological interventions in heart failure
He actively leads major research initiatives funded by NIHR, UKRI, and Bayer, including:
- DaRe2THINK: Preventing stroke and cognitive decline in atrial fibrillation
- Hypermarker: Personalized pharmacometabolomic hypertension treatment
- Thromboinflammation studies via NIHR BRC